CLEVELAND, March 10, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Cowen and Company 28th Annual Health Care Conference, to be held March 17-20, 2008, at The Boston Marriott Copley Place in Boston.
Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will present Monday, March 17, 2008 at 4:45 p.m. ET. The presentation will be available as a live, audio web cast and then archived for 90 days after at: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ATHX&item_id=1786575.
About Athersys, Inc.
Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. In addition to its lead product candidate, ATHX-105, the company is developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). Athersys is developing MultiStem(r), a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications.
The Athersys, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4548